Is trouble looming on the horizon for Microsoft with the number of Windows 10 diehards who might hold fast resisting an ...

The comeback rally has investors increasingly confident stocks have turned a corner on tariffs, though concerns remain.

CNBC's Jim Cramer said President Donald Trump's actions bring out short sellers and lead investors to make misguided market ...

KDE has launched a new "W10 for Exiles" campaign to encourage users to drop their plans for Windows 11 because Linux is ...

The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.

The British government might not have lost nearly as much on its stake in the bank had circumstances been different.

Stocks like Sun Pharmaceutical Industries, Zydus Lifesciences, Techno Electric & Engineering Company, R Systems International ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

In an era where healthcare innovation is accelerating at breakneck speed, a UK-based medical robotics firm is setting its sights on a colossal $4 billion sale opportunity. Positioned at the ...

The approval of such spot bitcoin ETFs in January 2024 by the U.S. Securities and Exchange Commission, marked a watershed moment for the digital assets industry ...

Unlike its predecessors, which straddled the line between mid-range and premium, the Phone (3) is expected to go "all-in," in the words of co-founder Carl Pei. While not confirmed, multiple sources ...